Lay clinical trial summaries

We are committed to ensuring that all our published research is freely available to everyone. We work closely with the patient community to provide summaries of key clinical studies sponsored by Ipsen in easy-to-understand language, so they are not just available, but accessible to all.

ONCOLOGY

Neuroendocrine tumours – Phase III CLARINET study

A study on the effectiveness of the treatment for patients with non-functioning neuroendocrine tumours of the pancreas, intestines or unknown origin.

Read the study

NEUROSCIENCE

Spasticity – Phase III ENGAGE study

A study to evaluate the effects of the treatment in patients living with spastic hemiparesis in combination with a prescribed personal rehabilitation program.

Read the study

RARE DISEASE

Fibrodysplasia Ossificans Progressive (FOP) – Burden of Illness study

A study to evaluate the impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members.

Read the study

Filter

Condition

Period

Filter by

Reset

Showing: 1 – 05 of 3 Conditions

Show

Sort

– 05 May 2023

05 May 2023

Fibrodysplasia ossificans progressiva burden of disease study

A study to evaluate the impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members.

– 05 May 2023

05 May 2023

Phase III ENGAGE study

A study to evaluate the effects of Dysport® in patients living with spastic hemiparesis in combination with a prescribed personal rehabilitation program.

– 05 May 2023

05 May 2023

Phase III CLARINET study

A study on the effectiveness of somatuline autogel (lanreotide autogel) as a treatment for patients with non-functioning neuroendocrine tumours of the pancreas, intestines, or unknown origin.